Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis

@inproceedings{Kalil2013TreatmentOH,
  title={Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis},
  author={Andre C Kalil and Michael Klompas and Gleb R. Haynatzki and Mark Edmund Rupp},
  booktitle={BMJ open},
  year={2013}
}
OBJECTIVE Hospital-acquired pneumonia remains the most lethal and expensive nosocomial infection worldwide. Optimal therapy remains controversial. We aimed to compare mortality and clinical response outcomes in patients treated with either linezolid or vancomycin. DESIGN Systematic review and meta-analysis. DATA SOURCES PubMed, EMBASE, Cochrane Library, American College of Physicians Journal Club, Evidence-based Medicine BMJ and abstracts from infectious diseases and critical care meetings… CONTINUE READING
View PDF
39 Citations
1 Highly Influenced Papers
11 Cite Background
5 Cite Results
1 Cite Methods
30
Twitter Mentions

Citations

Publications citing this paper.
SHOWING 1-10 OF 39 CITATIONS

Efficacy and safety of linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus ( MRSA )-related pneumonia : updated systematic review and meta-analysis

Wei Zhang, Ni Xu, +5 authors Xiaosong Li
  • 2019
VIEW 8 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

COMMUNITY-ACQUIRED PNEUMONIA IN THE INTENSIVE CARE UNIT What are the Common Organisms Causing Community-Acquired Pneumonia in Intensive Care Unit Worldwide and India ?

G. C. Khilnani, Kapil G. Zirpe, +8 authors Pradeep Bhattacharya
  • 2019

Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia

James M Kidd, Kamilia Abdelraouf, David P Nicolau
  • The Journal of antimicrobial chemotherapy
  • 2019

Pharmacotherapy of Lower Respiratory Tract Infections in Elderly—Focused on Antibiotics

Yang Liu, Yan Zhang, +3 authors Birong Dong
  • Front. Pharmacol.
  • 2019

Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment

Toshinori Hirai, Kazuhiko Hanada, Ayako Kanno, Megumi Akashi, Toshimasa Itoh
  • European Journal of Clinical Pharmacology
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

What Is the Evidence for Co-trimoxazole, Clindamycin, Doxycycline, and Minocycline in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia?

Jenny Hong, Mary H H Ensom, Tim T. Y. Lau
  • The Annals of pharmacotherapy
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND

Antibiotic dosing for multidrug-resistant pathogen pneumonia

Mohd H Abdul-Aziz, Jeffrey Lipman, Jason A Roberts
  • Current opinion in infectious diseases
  • 2017

Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones

Claire Roger, Jason A Roberts, Laurent Muller
  • Clinical Pharmacokinetics
  • 2017

Efficacy of Intermittent and Continuous Subglottic Secretion Drainage in Ventilator-Associated Pneumonia Reduction among Critically Ill Ventilated Patients : An Integrative Review

Abdulmohsen Mohammed Folos, Mohammed Ageel Ahmed, +4 authors Ali Mohammed Abu Tawil
  • 2017
VIEW 2 EXCERPTS
CITES BACKGROUND

Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus in Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia at Tertiary Care Hospital

Eman Hamdan, Majda Alattas
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 29 REFERENCES

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.

Andre C Kalil, M. V. H. Bhaskara Murthy, +3 authors Mark Edmund Rupp
  • Critical care medicine
  • 2010
VIEW 6 EXCERPTS

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

Saadvi Kethireddy, Aseem Kumar
  • 2012
VIEW 1 EXCERPT

Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.

Richard G Wunderink, Michael S. Niederman, +6 authors Jean Chastre
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
VIEW 1 EXCERPT

Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.

Allan J Walkey, Max R. O’Donnell, Renda Soylemez Wiener
  • Chest
  • 2011

Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit

M Sanchez Garcia, MA De la Torre, G Morales
  • JAMA
  • 2010
VIEW 1 EXCERPT

Linezolid versus vancomycin for the treatment of gram-positive bacterial infections: meta-analysis of randomised controlled trials.

Liang Bei-bei, Cai Yun, +3 authors Wang Rui
  • International journal of antimicrobial agents
  • 2010

New phase 4 study shows higher rates of clinical and microbiological success for zyvox versus vancomycin in MRSA nosocomial pneumonia

Pfizer Report
  • 2010
VIEW 1 EXCERPT

Power Analysis for Meta‐Analysis

Michael Dale Borenstein, Larry V Hedges, Julian P T Higgins, Hannah R. Rothstein
  • 2009
VIEW 1 EXCERPT

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

David Moher, Alessandro Liberati, Jennifer Marie Tetzlaff, Douglas G. Altman
  • BMJ
  • 2009

Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.

Richard G Wunderink, Meryl H. Mendelson, +5 authors Joseph S. Solomkin
  • Chest
  • 2008